Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

BRBRTX
6 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in BIORESTORATIVE THERAPIES INC

CITADEL ADVISORS LLC holds 273,304 shares of BRTX (BIORESTORATIVE THERAPIES INC), worth $102,762 as of 2026-Q2. The position was increased (+14.5% shares).

Current Value

$102,762

Current Shares

273,304

Total Value Change

+$72,044

Total Shares Change

+251,823

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
273,304
+14.5%
$102,7620.0%$0.38
17
2026-Q1
Increased
238,606
+717.2%
$64,9250.0%$0.21
23
2025-Q4
Decreased
29,198
-72.5%
$34,1620.0%$1.17
0
2025-Q3
New
106,210
-
$151,8800.0%$1.45
34
2025-Q1
Exited
0
-100.0%
$00.0%$1.81
0
2024-Q4
New
21,481
-
$30,7180.0%$1.44
30

Other major holders of BRTX: JANE STREET GROUP, LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Mariner, LLC, TWO SIGMA ADVISERS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used